| Discrimination between Risk Profiles for Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma using Metabolomic Analysis |
Linda Liao |
NCI, DCEG, OEEB |
PLCO |
Nov 14, 2011 |
2011-0166 |
| Mucins, anti-mucin antibodies and immune complexes as risk and early detection biomarkers for ovarian cancer |
Daniel W. Cramer |
Brigham and Women's Hospital |
PLCO |
Nov 14, 2011 |
2011-0157 |
| Dietary fat, prediction of insulin-related and inflammatory biomarkers and pancreatic cancer risk |
Rachael Stolzenberg-Solomon |
NCI, DCEG, NEB |
PLCO |
Nov 3, 2011 |
2011-0225 |
| Feasibility of Establishing a Second Cancer Cohort Consortium |
Amanda Black |
NCI, DCEG, EBP |
PLCO |
Nov 3, 2011 |
2011-0232 |
| Risk factors for second cancers among survivors of tobacco- and alcohol-related cancers |
Meredith Shiels |
NCI, DCEG, IIB |
PLCO |
Nov 3, 2011 |
2011-0234 |
| Risk factors for second cancers among colorectal cancer survivors in a cohort consortium |
Todd Gibson |
NCI, DCEG, REB |
PLCO |
Nov 3, 2011 |
2011-0235 |
| Development and validation of a lung cancer risk prediction model |
Martin Tammemagi |
Henry Ford Health System |
NLST |
Oct 25, 2011 |
201110-0018 |
| Development and validation of a pancreatic cancer risk prediction model |
Martin Tammemagi |
Henry Ford Health System |
NLST |
Oct 25, 2011 |
201110-0021 |
| Factors associated with small aggressive NSCLC abnormal suspicious CXR screens. |
Martin Tammemagi |
Henry Ford Health System |
NLST |
Oct 25, 2011 |
201110-0017 |
| Relative Survival (excess mortality) of individuals diagnosed with lung cancer in the National Lung Screening Trial. |
Martin Tammemagi |
Henry Ford Health System |
NLST |
Oct 25, 2011 |
201110-0019 |
| CT Indiviual Dose Project (STARS ASA Proposal ID- 201012-0028) |
Michael Flynn |
Henry Ford Health System |
NLST |
Oct 25, 2011 |
201110-0020 |
| Dietary Intake of Vitamin K and Risk of Prostate Cancer |
Jianjun Zhang |
Indiana University |
PLCO |
Oct 6, 2011 |
2011-0121 |
| Obesity and incidence of rare cancers (thyroid, gallbladder, head and neck) in the NCI Cohort Consortium |
Cari Kitahara |
NCI, DCEG, NEB |
PLCO |
Oct 6, 2011 |
2011-0207 |
| Male pattern baldness and prostate cancer risk: a prospective study in PLCO |
Michael Cook |
NCI, DCEG, HREB |
PLCO |
Oct 6, 2011 |
2011-0231 |
| Ovarian Cancer Biomarkers: Serial CA-125 + Other Markers + Clinical Variables |
Stuart Baker |
NCI, DCP, BRG |
PLCO |
Sep 22, 2011 |
2011-0195 |
| Association between genetic variation and circulating selenium concentrations |
Ulrike Peters |
Fred Hutchinson Cancer Research Center |
PLCO |
Sep 22, 2011 |
2011-0205 |
| Leisure-time physical activity and risk of cancer in the Cohort Consortium |
Steven Moore |
Extramural |
PLCO |
Sep 22, 2011 |
2011-0206 |
| Association between body mass index and mortality in non-Hispanic blacks |
Cari Kitahara |
NCI, DCEG, NEB |
PLCO |
Sep 22, 2011 |
2011-0229 |
| Development and validation of an endometrial cancer risk prediction model |
Jennifer Prescott |
Brigham and Women's Hospital / Harvard Medical School |
PLCO |
Sep 9, 2011 |
2011-0122 |
| Inflammatory Markers and Risk of Colorectal Cancer |
Sonja Berndt |
NCI |
PLCO |
Aug 31, 2011 |
2011-0191 |
